Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma
在拉丁美洲多国队列研究中，不可切除肝细胞癌患者接受阿特珠单抗和贝伐珠单抗治疗后发生的免疫介导不良事件
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28721
da Fonseca, Leonardo Gomes; Piñero, Federico; Anders, Margarita; Bermudez, Carla; Demirdjian, Ezequiel; Varón, Adriana; Perez, Daniela; Rodriguez, Jorge; Beltrán, Oscar; Ridruejo, Ezequiel; Caballini, Pablo; Araujo, Alexandre; Florez, Juan Diego Torres; Marín, Juan Ignacio; Villa, Marina; Orozco, Federico; Poniachik, Jaime; Marciano, Sebastián; Bessone, Fernando; Mendizabal, Manuel
